VLC 2025 | A Look at the NIH and FDA Through a CF Lens скачать в хорошем качестве

VLC 2025 | A Look at the NIH and FDA Through a CF Lens

For years, the CF Foundation has advocated for the National Institutes of Health and the U.S. Food and Drug Administration because of the critical role they play in advancing cystic fibrosis treatment, helping bring 17 groundbreaking therapies to patients. During our 21st Volunteer Leadership Conference, our advocacy panel delves into the vital role these institutions play in drug discovery and development, highlighting their ongoing importance in the quest to ensure that every person with CF has a treatment for their specific mutation—and ultimately, a cure. Originally recorded April 5, 2025. 00:00 | VLC 2025: A Look at the NIH and FDA Through a CF Lens 1:01 | Why are the FDA and NIH integral to CF science? 2:59 | How have the CF Foundation and the NIH worked together over the years? 6:52 | Tara Kent, a mother to two children with CF, discusses why her children participate in clinical trials 10:56 | How do research grants work? 14:42 | What are indirect costs? 21:40 | How do the NIH and FDA partner to deliver therapeutic treatments? 26:07 | Tara discusses the factors she considered when deciding whether to enroll her children in clinical trials 32:40 | How does federal funding contribute to the CF Foundation’s Therapeutics Development Network? 38:26 | How have cuts at the FDA and NIH resulted in grants being delayed? 41:24 | How important is the federal government in funding the next generation of researchers? 44:46 | Why is the FDA an essential partner to the CF Foundation? 53:25 | Tara challenges the audience to share their CF stories